FROG FROG
Company Profile ↓Company Overview
FROG (FROG) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 35.5% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $531.84M (+24.1% YoY); net profit $-71.82M.
- Trailing 12 Months Year-on-year growth — revenue +24.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 35.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 35.46% |
| 1 Year: | 24.12% |
Stock Price Performance
| 1 Year: | +94.75% |
| 6 Months: | +63.17% |
| 3 Months: | +55.34% |
| 1 Month: | -12.14% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)51.59 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 35.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.84M | 32.82M | 36.43M | 38.89M | 45.09M | 48.66M | 53.70M | 63.70M | 67.81M | 71.99M | 79.82M | 84.17M | 88.64M | 100.31M | 103.04M | 109.06M | 122.41M | 127.22M | 136.91M | 153.98M |
| Gross Profit | 22.50M | 26.42M | 29.74M | 31.62M | 36.66M | 39.59M | 42.24M | 49.83M | 52.56M | 56.09M | 61.40M | 65.72M | 68.89M | 79.71M | 81.15M | 81.77M | 92.23M | 97.02M | 106.01M | 120.38M |
| Operating Income | -3.32M | -2.10M | 1.34M | -5.40M | -10.61M | -14.23M | -20.92M | -19.14M | -22.41M | -23.44M | -23.21M | -18.91M | -18.05M | -16.64M | -19.13M | -29.92M | -22.97M | -25.97M | -21.59M | -12.93M |
| Net Income | -3.11M | -2.12M | 1.70M | -5.26M | -7.89M | -13.15M | -20.46M | -19.70M | -23.77M | -23.55M | -20.81M | -15.47M | -13.75M | -8.79M | -14.30M | -22.95M | -18.50M | -21.68M | -16.43M | -8.27M |
| Diluted EPS | - | - | 0.00 | - | - | -0.14 | -0.21 | -0.20 | -0.24 | -0.24 | -0.21 | -0.15 | -0.13 | -0.08 | -0.13 | -0.21 | -0.16 | -0.19 | -0.14 | -0.07 |
| R&D Expense | 8.66M | 9.29M | 9.78M | 10.38M | 13.84M | 16.69M | 23.14M | 27.10M | 28.95M | 31.70M | 34.89M | 33.54M | 33.36M | 35.83M | 37.12M | 43.00M | 43.34M | 47.42M | 51.17M | 51.81M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.53M | 104.72M | 150.83M | 206.68M | 280.04M | 349.89M | 428.49M | 531.84M |
| Gross Profit | 52.82M | 84.68M | 122.38M | 164.86M | 217.75M | 272.84M | 330.19M | 408.39M |
| Operating Income | -26.86M | -6.94M | -14.19M | -68.37M | -89.84M | -75.55M | -91.10M | -91.85M |
| Net Income | -26.02M | -5.39M | -9.40M | -64.20M | -90.18M | -61.26M | -69.24M | -71.82M |
| Diluted EPS | - | - | -0.20 | -0.68 | -0.91 | -0.59 | -0.63 | -0.62 |
| R&D Expense | 25.86M | 29.73M | 41.11M | 79.60M | 121.22M | 134.58M | 160.86M | 195.09M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 238.04M | 689.23M | 852.53M | 871.22M | 972.56M | 1.13B | 1.34B |
| Total Equity | -38.02M | -38.68M | -33.43M | 553.89M | 638.58M | 624.77M | 679.12M | 773.53M | 887.45M |
| Cash & Equivalents | - | 177.88M | 39.15M | 164.46M | 68.28M | 45.59M | 84.77M | 49.87M | 75.84M |
| Total Liabilities | - | - | 95.63M | 135.34M | 213.95M | 246.45M | 293.43M | 356.38M | 453.93M |
| Current Liabilities | - | - | 86.00M | 122.70M | 175.26M | 209.57M | 262.18M | 317.51M | 407.52M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.56M | 10.00M | 29.46M | - | 21.43M | 74.16M | 110.92M | 145.73M |
| Investing Cash Flow | -3.08M | -149.59M | -311.80M | - | -53.34M | -53.48M | -165.36M | -152.27M |
| Financing Cash Flow | 114.48M | 736.00K | 406.13M | - | 11.03M | 18.37M | 21.23M | 31.21M |
| Capital Expenditure | -2.08M | -1.80M | -3.52M | - | -4.63M | -1.98M | -3.14M | -3.46M |
| Free Cash Flow | 6.49M | 8.20M | 25.94M | - | 16.80M | 72.17M | 107.78M | 142.27M |
| Net Change in Cash | - | - | - | - | -20.89M | 39.05M | -33.20M | 24.67M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 83.1% | 80.9% | 81.1% | 79.8% | 77.8% | 78.0% | 77.1% | 76.8% |
| Operating Margin % | -42.3% | -6.6% | -9.4% | -33.1% | -32.1% | -21.6% | -21.3% | -17.3% |
| Net Margin % | -40.9% | -5.2% | -6.2% | -31.1% | -32.2% | -17.5% | -16.2% | -13.5% |
| ROE % | 67.3% | 16.1% | -1.7% | -10.1% | -14.4% | -9.0% | -9.0% | -8.1% |
| ROCE % | - | -4.6% | -2.5% | -10.1% | -13.6% | -10.6% | -11.2% | -9.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FROG
A JFrog Director Sold Company Shares Worth $2.2 Million Amid a Massive Surge in Share Price. Here's a Deeper Look at the Sale.
This DevOps software solutions leader reported a notable insider sale amid a 115% stock surge over the past year.
JFrog to Present at Upcoming Investor Conferences
SUNNYVALE, Calif., July 28, 2026--JFrog will present at the KeyBanc and Canaccord Genuity investor conferences during the third quarter of 2026.
JFrog Faces Strong Artifactory Consumption, Curation Demand, Oppenheimer Says
JFrog (FROG) faces strong Artifactory consumption, a robust pipeline, rising Curation demand, and gr
JFrog (FROG) Could Be 7% Overvalued After Canada Government Catalogue Win
JFrog (FROG) is back on radars after its software supply chain platform was added to the Government of Canada's Software Licensing Supply Arrangement Catalogue, giving federal agencies a formal route to procure its tools. See our latest ana…
JFrog and DCI Enable Canadian Public Sector Organizations to Rapidly Respond to Evolving Software Transparency Standards
SUNNYVALE, Calif. & OTTAWA, Ontario, July 13, 2026--JFrog and DCI Enable Canadian Public Sector Organizations to Rapidly Respond to Evolving Software Transparency Standards
UBS Raises its Price Target on JFrog (FROG)
JFrog Ltd. (NASDAQ:FROG) is one of the 8 High Growth Cybersecurity Stocks to Buy Now. On July 2, 2026, UBS analyst Radi Sultan raised the firm’s price target on JFrog Ltd. (NASDAQ:FROG) to $110 from $92 and kept a Buy rating on the shares. …
FROG — Frequently Asked Questions
What is the current share price of FROG?
As of 2026-08-05 17:25 PDT, FROG trades at $84.52 on NASDAQ/NYSE. Its 52-week range is $34.75 to $98.10.
What is the P/E ratio of FROG?
FROG trades at a trailing price-to-earnings (P/E) ratio of -136.32.
What is the return on equity (ROE) of FROG?
FROG has a return on equity (ROE) of -8.09%. Its return on capital employed (ROCE) is -9.84%.
Is FROG a good stock to buy?
This page provides a data-driven analysis of FROG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.